Evaluation of antibacterial and antiviral activity of N-arylamides of 9-methyl-and 9-methoxyphenazine-1-carboxylic acids - Inhibitors of the phage T7 model transctiption

Biopolymers and Cell

Volumn 28, Issue 6, 2012, Pages 477-485

  Palchykovska, L G ^a   Vasylchenko, O V ^a   Platonov, M O ^a   Kostina, V G ^a   Babkina, M M ^b   Tarasov, O A ^b   Starosyla, D B ^c   Samijlenko, S P ^a   Rybalko, S L ^c   Deriabin, O M ^b   Hovorun, D M ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b Ukrainian Academy of Agrarian Sciences Kiev   (Ukraine)

^c Gromashevsky L V Institute of epidemiology and infection diseases AMS of Ukraine   (Ukraine)

Author keywords

Antibacterial activity; Antiviral activity; Model system of the DNA dependent RNA polymerase of phage T7; N arylamides 9 substituted PCA

Indexed keywords

9 METHOXY PHENAZINE 1 CARBOXYLIC ACID; 9 METHYL PHENAZINE 1 CARBOXYLIC ACID; AROMATIC AMIDE; ENZYME INHIBITOR; PHENAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BOVINE DIARRHEA VIRUS; DRUG CYTOTOXICITY; ERYSIPELOTHRIX RHUSIOPATHIAE; ESCHERICHIA COLI; IC 50; IN VITRO STUDY; KLEBSIELLA; LIQUID CULTURE; NONHUMAN; RNA SYNTHESIS;

BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1; ERYSIPELOTHRIX RHUSIOPATHIAE; ESCHERICHIA COLI; KLEBSIELLA; NEGIBACTERIA; POSIBACTERIA;

EID: 84872244349     PISSN: 02337657     EISSN: 19936842     Source Type: Journal    
DOI: 10.7124/bc.00013A     Document Type: Article

References (33)

1. Maratz H. R. The origin of new diseases. The World Book Health and Medical Annual. Portland: World Book, Inc., 1995. P. 45-59.
2. Arias C. A., Murray B. E. Antibiotic-resistant bugs in the 21st century a clinical super-challenge. N. Engl. J. Med. 2009. 360, N 5. P. 439-443.
3. De Logu A., Palchykovska L. H., Kostina V. H., Sanna A., Meleddu R., Chisu L., Alexeeva I. V., Shved A. D. Novel N-aryland N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis. Int. J. Antimicrob. Agents. 2009. 33, N 3. Ð. 223-229.
4. Palchykovska L. G., Alexeeva I. V., Kostina V. G., Platonov M. O., Negrutska V. V., Deriabin O. M., Tarasov O. A., Shved A. D. New amides of phenazine-1-carboxylic acid: antimicrobial activity and structure-activity relationship. Ukr. Biochem. J. 2008. 80, N 3. P. 142-146.
5. Das K., Lewi P. J., Hughes S. H, Arnold E. Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors. Prog. Biophys. Mol. Biol. 2005. 88, N 2-p. 209-231.
6. Das K., Clark A. D. Jr., Lewi P. J., Heeres J., De Jonge M. R., Koymans L. M., Vinkers H. M., Daeyaert F., Ludovici D. W., Kukla M. J., De Corte B., Kavash R. W., Ho C. Y., Ye H., Lichtenstein M. A., Andries K., Pauwels R., De Bethune M. P., Boyer P. L., Clark P., Hughes S. H., Janssen P. A., Arnold E. Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. J. Med. Chem. 2004. 47, N 10. P. 2550-2560.
7. Sahlberg C., Xiao-Xiong Z. Development of non-nucleoside reverse transcriptase inhibitors for anti-HIV therapy. Antiinfect. Agents Med. Chem. 2008. 7, N 2. P. 101-117.
8. Cano F. R., Kuo S. C., Lampen J. O. Lomofungin, an inhibitor of deoxyribonucleic acid-dependent ribonucleic acid polymerases. Antimicrobial. Agents Chemother. 1973. 3, N 6. P. 723-728.
9. Rewcastle G. W., Denny W. A., Baguley B. C. Potential antitumor agents. 51. Synthesis and antitumor activity of substituted phenazine-1-carboxamides. J. Med. Chem. 1987. 30, N 5. P. 843-851.
10. Gamage S. A., Rewcastle G. W., Baguley B. C., Charlton P. A., Denny W. A. Phenazine-1-carboxamides: structure-cytotoxicity relationships for 9-substituents and changes in the H-bonding pattern of the cationic side chain. Bioorg. Med. Chem. 2006. 14, N 4. P. 1160-1168.
11. Palchykovska L. G., Vasylchenko O. V., Platonov M. O., Kostina V. G., Lysenko N. A., Alexeeva I. V., Hovorun D. M., Shved A. D. Design of transcription inhibitors on the basis of N-arylamides of 9-methyl-and 9-methoxyphenazine-1-carboxylic acids. Ukr. Biochem. J. 2011. 83, N 2. P. 65-72.
12. Rao Y.M., Sureshkumar G. K. Oxidative-stress-induced production of pyocyanin by Xanthomonas campestris and its effect on the indicator target organism, Escherichia coli. J. Ind. Microbiol. Biotechnol. 2000. 25, N 5. P. 266-272.
13. Price-Whelan A., Dietrich L. E., Newman D. K. Rethinking «secondary» metabolism: physiological roles for phenazine antibiotics. Nat. Chem. Biol. 2006. 2. N 2. P. 71-78.
14. Hollstein U., Van Gemert R. J. Jr. Interaction of phenazines with polydeoxyribonucleotides. Biochemistry. 1971. 10, N 3. P. 497-504.
15. Hollstein U., Butler P. L. Inhibition of ribonucleic acid synthesis by myxin. Biochemistry. 1972. 11, N 8. P. 1345-1350.
16. Turner J. M., Messenger A. J. Occurrence, biochemistry and physiology of phenazine pigment production. Adv. Microb. Physiol. 1986. 27. P. 211-275.
17. Kerr J. R. Phenazine pigments: antibiotics and virulence factors. Infect. Dis. Rev. 2000. 29. P. 184-194.
18. Stankiewicz-Drogon A., Palchykovska L. G., Kostina V. G., Alexeeva I. V., Shved A. D., Boguszewska-Chachulska A. M. New acridone-4-carboxylic acid derivatives as potential inhibitors of hepatitis C virus infection. Bioorg. Med. Chem. 2008. 16, N 19. P. 8846-8852.
19. Palchykovska L. G., Alexeeva I. V., Platonov M. O., Kostenko O. M., Usenko L. S., Negrutska V. V., Shved A. D. New 1,2,4-triazine bearing compounds: molecular modeling, synthesis and biotesting. Biopolym. Cell. 2009. 25, N 6. P. 491-499.
20. Palchykovska L. G., Alexeeva I. V., Negrutska V. V., Kostyuk Yu. K., Indychenko T. M., Kostenko O. M., Kryvorotenko D. V., Shved A. D., Dubey I. Ya. Inhibition of in vitro transcription by 2-arylidene derivatives of thiazolo[3,2-]benzimidazol-3(2H)-one. Biopolym. Cell. 2010. 26, N 6. P. 508-511.
21. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically/Third ed. Approved Standard NCCLS Document M7-A3.1993. 13, No. 25, NCCLS, Villanova, PA, December 1993.
22. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically/3rd ed.. Approved standard M7-A3. National Committee for Clinical Laboratory Standards. Villanova, 1993.
23. Luber P., Bartelt E., Genschow E., Wagner J., Hahn H. Comparison of broth microdilution, E Test, and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni and Campylobacter coli. J. Clin. Microbiol. 2003. 41, N 3. P. 1062-1068.
24. Jorgensen J. H., Turnidge J. D., Washington J. A. Antibacterial susceptibility tests: dilution and disk diffusion methods. Manual of clinical microbiology/Eds P. R. Murray et. al., 9th ed. Washington: Am. Soc. Microbiol. publ., 2007. P. 1152-1172
25. Shimizu Y. K., Yoshikura H. Cell culture systems for the detection of HCV infection. Methods Mol. Med. 1999. 19. P. 483-488.
26. Basch H., Gadebusch H. H. In vitro antimicrobial activity of dimethylsulfoxide. Appl. Microbiol. 1968. 16, N 12. P. 1953-1954.
27. Delarue M., Poch O., Tordo N., Moras D., Argos P. An attempt to unify the structure of polymerases. Protein Eng. 1990. 3, N 6. P. 461-467.
28. Tunitskaya V. L., Kochetkov S. N. Structural-functional analysis of bacteriophage T7 RNA polymerase. Biochemistry (Mosc). 2002. 67, N 10. P. 1124-1135.
29. Dennehy J. J. Bacteriophages as model organisms for virus emergence research. Trends Microbiol. 2009. 17. N 10. P. 450-457.
30. Egyeki M., Turoczy G., Majer Z., Toth K., Fekete A., Maillard P., Csik G. Photosensitised inactivation of T7 Phage as surrogate of non-enveloped DNA viruses: efficiency and mechanism of action. Biochim. Biophys. Acta. 2003. 1624, N 1-3. P. 115-124.
31. Goens S. D. The evolution of bovine viral diarrhea. Can. Vet. J. 2002. 43, N 12. P. 946-954.
32. Buckwold V. E., Beer B. E., Donis R. O. Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents. Antiviral Res. 2003. 60, N 1. P. 1-15.
33. Sousa R. Structural and mechanistic relationships between nucleic acid polymerases. Trends Biochem. Sci. 1996. 21, N 5. P. 186-190.